EXTEND (Eltrombopag Extended Dosing Study) (EXTEND)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novartis
ClinicalTrials.gov Identifier:
NCT00351468
First received: July 10, 2006
Last updated: March 22, 2016
Last verified: March 2016